Association of Selected Genetic Variants in CYP1A1, CYP2D6, NAT1 and NAT2 with Endometrial Cancer Risk: A Preliminary Case-Control Study. [PDF]
Skrzypek M +5 more
europepmc +1 more source
Preliminary Evidence for Sex Differences in CYP2C19 Metabolic Capacity During Psychotropic Drug Treatment. [PDF]
Eiberger J +6 more
europepmc +1 more source
Precision medicine decision-making under pharmacogenomics in nursing: realizing value from limited evidence to scaled clinical pathways. [PDF]
Qin G +9 more
europepmc +1 more source
Repositioning candidate gene approaches in the post-GWAS era: a clinical perspective from psychiatric pharmacogenetics. [PDF]
Pjevac M, Bon J, Dolžan V.
europepmc +1 more source
Molecular Mechanisms of Acute Drug Toxicity in Polypharmacy: Analgesic-Psychotropic Interactions. [PDF]
Rijavec N, Rijavec B.
europepmc +1 more source
Very strong correlations of metoprolol- and solanidine-derived metabolic ratios in a real-world cohort with a stable metoprolol drug regimen. [PDF]
Sarömba JA +17 more
europepmc +1 more source
Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two-Injection Start Regimen with Aripiprazole Once-Monthly Long-Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder. [PDF]
Yamasaki Y +10 more
europepmc +1 more source
Advancing Personalized Medicine in Psychiatry: A Descriptive Pilot Study Integrating Pharmacogenetics and Pharmacokinetics in Long-Acting Antipsychotic Treatment. [PDF]
Gil-Rodriguez A +18 more
europepmc +1 more source
Clinical CYP2D6-Mediated Pharmacokinetic Drug-Drug Interactions of DA-8010 with Paroxetine or Mirabegron in Healthy Korean Participants. [PDF]
Ryu H, Cho JY, Lee DY, Lee S.
europepmc +1 more source

